4214 2.5 (Onglyza saxagliptin 2.5 mg)
Generic Name: saxagliptin
Pill imprint 4214 2.5 has been identified as Onglyza saxagliptin 2.5 mg.
Onglyza is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Onglyza saxagliptin 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 4214 2.5 (Onglyza saxagliptin 2.5 mg)
Onglyza
- Generic Name:
- saxagliptin
- Imprint:
-
4214
2.5 - Strength:
- saxagliptin 2.5 mg
- Color:
- Yellow
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-4214
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
More resources
Onglyza is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
